The
Carnot Institution label was created in 2006 to accredit excellence in research
establishments. It functions on a call for candidates model and seeks to bring
together actors in public research and socioeconomics with the goals of
speeding the arrival of innovations and empowering the transfer of technologies
to economic stakeholders.
The
Ministry for Higher Education, Research and Innovation recently announced the 37
laureates of its 5 June 2019 call for
accreditation. Among these new Carnot Institutes was the Organization for
Partnerships in Leukemia (OPALE).
This
first accreditation for OPALE recognizes an unrivaled international consortium
for research in leukemia and its related disorders, the most deadly of the
blood cancers. The incidence of leukemia is currently
growing and across the globe, 2.3 million people are battling it today.
Leukemia is also the leading cancer in children.
With
the objective of structuring joint research in France for this pathology, the
OPALE Carnot Institute brings together 16 research units, 6 clinical research
cooperation groups, and 4 development facilities. Together these entities cover
research & development and medical valorization & industrialization at
the highest level.
Two
divisions of the François Jacob Institute of Biology are among those entities,
specifically IDMIT, a research infrastructure for human infectious diseases and
immunology, and IRCM, the Research Institute for Cellular and Molecular Radiobiology.